Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: The LUCIE Study;Coste económico directo del control y el tratamiento del lupus eritematoso sistémico activo y sus brotes en España: estudio LUCIE Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study

Revista Clinica Espanola

Volumn 213, Issue 3, 2013, Pages 127-137

  Cervera, R ^a   Rua Figueroa I ^b   Gil Aguado, A ^c   Sabio, J M ^d   Pallares L ^e   Hernandez Pastor L J ^f   Iglesias, M ^f  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Servicio de Medicina Interna   (Spain)

^e Servicios de Medicina Interna   (Spain)

^f GLAXOSMITHKLINE   (Spain)

Author keywords

Disease activity; Health resources; Healthcare resources cost; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ADULT; ARTICLE; COST OF ILLNESS; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICAL SPECIALIST; RETROSPECTIVE STUDY; SPAIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; DISEASE PROGRESSION; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84879839584     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2012.11.018     Document Type: Article

References (28)

1. S. O'Neill, and R. Cervera Systemic lupus erythematosus Best Pract Res Clin Rheumatol 24 2010 841 855
2. P. López, L. Mozo, C. Gutiérrez, and A. Suárez Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features Lupus 12 2003 860 865
3. M.D. Alonso, J. Llorca, F. Martinez-Vazquez, J.A. Miranda-Filloy, T. Diaz de Teran, and T. Dierssen Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study Medicine (Baltimore) 90 2011 350 358
4. Sociedad Española de Reumatología. Proyecto EPISER 2000: Prevalencia e impacto de las enfermedades reumáticas en la población española. Madrid, marzo 2001 [consultado 26 Abr 2012]. Disponible en: www.ser.es/investigacion/Proyectos/Episer/Episer.php
5. M. Petri, S.G. Barr, A. Zonana-Nacach, and L. Magder Measures of disease activity, damage, and health status: the Hopkins Lupus Cohort experience J Rheumatol 26 1999 502 503
6. S. Barr, A. Zonana-Nacach, L. Magder, and M. Petri Patterns of disease activity in systemic lupus erythematosus Arthritis Rheum 42 1999 2682 2688
7. R. Cervera, and J. Font Perspectivas terapéuticas en el lupus eritematoso sistémico Med Clin (Barc) 123 2004 540 542
8. M.B. Urowitz, D.D. Gladman, D. Ibañez, P.R. Fortin, S.C. Bae, and C. Gordon Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort Arthritis Care Res (Hoboken) 64 2012 132 137
9. D.D. Gladman, M.B. Urowitz, P. Rahman, D. Ibañez, and L.S. Tam Accrual of organ damage over time in patients with systemic lupus erythematosus J Rheumatol 30 2003 1955 1959
10. G. Bertsias, J.P. Ioannidis, J. Boletis, S. Bombardieri, R. Cervera, C. Dostal Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics Ann Rheum Dis 67 2008 195 205
11. Guías clínicas de enfermedades autoinmunes sistémicas de la sociedad española de medicina interna (SEMI). Grupo de Estudio de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna(SEMI). Lupus eritematoso sistémico, 2011.
12. S. Danoff-Burg, and F. Friedberg Unmet needs of patients with systemic lupus erythematosus Behav Med 35 2009 5 13
13. R. Campbell Jr., G.S. Cooper, and G.S. Gilkeson The impact of systemic lupus erythematosus on employment J Rheumatol 36 2009 2470 2475
14. S.A. Chambers, E. Allen, A. Rahman, and D. Isenberg Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years Rheumatology (Oxford) 48 2009 673 675
15. C.S. Lau, and A. Mak The socioeconomic burden of SLE Nat Rev Rheumatol 5 2009 400 404
16. Base de datos E-Salud. Oblikue Consulting. [Base de datos electrónica] [consultado May 2011]. Disponible en: www.oblikue.com/en/ index.htm
17. Base de datos BOT Plus. Consejo General de Colegios Oficiales de Farmacéuticos. [Base de datos electrónica] [consultado May 2011]. Disponible en: https://botplusweb.portalfarma.com
18. M. Petri, M.Y. Kim, K.C. Kalunian, J. Grossman, B.H. Hahn, L.R. Sammaritano OC-SELENA Trial Combined oral contraceptives in women with systemic lupus erythematosus N Engl J Med 353 2005 2550 2558
19. A.E. Clarke, M. Petri, S. Manzi, D.A. Isenberg, C. Gordon, J.L. Senécal Tri-Nation Study Group The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome Rheumatology (Oxford) 43 2004 1016 1024
20. T.Y. Zhu, L.S. Tam, and E.K. Li Cost-of-illness studies in systemic lupus erythematosus: a systematic review Arthritis Care Res (Hoboken) 63 2011 751 760
21. T.Y. Zhu, L.S. Tam, V.W. Lee, K.K. Lee, and E.K. Li Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong Rheumatology (Oxford) 48 2009 564 568
22. T. Li, G.S. Carls, P. Panopalis, S. Wang, T.B. Gibson, and R.Z. Goetzel Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population Arthritis Rheum 61 2009 755 763
23. D. Huscher, S. Merkesdal, K. Thiele, H. Zeidler, M. Schneider, A. Zink for the German Collaborative Arthritis Centres Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany Ann Rheum Dis 65 2006 1175 1183
24. A.E. Clarke, P. Panopalis, M. Petri, S. Manzi, D.A. Isenberg, and C. Gordon SLE patients with renal damage incur higher health care costs Rheumatology (Oxford) 47 2008 329 333
25. E.M. Pelletier, S. Ogale, E. Yu, P. Brunetta, and J. Garg Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database Clin Ther 31 2009 2653 2664
26. T.Y. Zhu, L.S. Tam, V.W. Lee, K.K. Lee, and E.K. Li The impact of flare on disease costs of patients with systemic lupus erythematosus Arthritis Rheum 61 2009 1159 1167
27. N. Sutcliffe, A.E. Clarke, R. Taylor, C. Frost, and D.A. Isenberg Total costs and predictors of costs in patients with systemic lupus erythematosus Rheumatology (Oxford) 40 2001 37 47
28. P. Panopalis, M. Petri, S. Manzi, D.A. Isenberg, C. Gordon, J.L. Senécal Tri-Nation Study Group The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs Arthritis Rheum 57 2007 64 70